09/30/2025 3:03 PM | MANNKIND CORP (Filed by) scPharmaceuticals (Subject)
| Form SC TO-T/A | |
09/29/2025 3:11 PM | scPharmaceuticals (Subject)
| Form SC 14D9/A | |
09/29/2025 3:01 PM | MANNKIND CORP (Filed by) scPharmaceuticals (Subject)
| Form SC TO-T/A | |
09/24/2025 7:45 AM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/24/2025 7:31 AM | MANNKIND CORP (Filed by) scPharmaceuticals (Subject)
| Form SC TO-T/A | |
09/24/2025 7:40 AM | scPharmaceuticals (Subject)
| Form SC 14D9/A | |
09/22/2025 7:31 AM | MANNKIND CORP (Filed by) scPharmaceuticals (Subject)
| Form SC TO-T/A | |
09/22/2025 7:38 AM | scPharmaceuticals (Subject)
| Form SC 14D9/A | |
09/10/2025 1:34 PM | GLAZER CAPITAL, LLC (Filed by) scPharmaceuticals (Subject)
| Form SCHEDULE 13G | |
08/25/2025 3:20 PM | MANNKIND CORP (Filed by) scPharmaceuticals (Subject)
| Form SC TO-C | |
08/25/2025 3:15 PM | scPharmaceuticals (Subject)
| Form SC14D9C | |
Get the Latest News and Ratings for SCPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
08/25/2025 7:46 AM | MANNKIND CORP (Filed by) scPharmaceuticals (Subject)
| Form SC TO-C | |
08/25/2025 6:33 AM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2025 6:35 AM | scPharmaceuticals (Subject)
| Form SC14D9C | |
08/25/2025 5:02 AM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2025 4:31 PM | Agger Mette Kirstine (Reporting) scPharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 3:48 PM | scPharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 3:49 PM | Bonstein Sara (Reporting) scPharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 3:59 PM | Baylor-Henry Minnie (Reporting) scPharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 3:18 PM | scPharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/21/2025 3:12 PM | scPharmaceuticals (Filer)
| Form DEFA14A | |
03/19/2025 4:27 PM | scPharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/19/2025 4:20 PM | scPharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2025 3:27 PM | Nokes Rachael (Reporting) scPharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 9:56 AM | KING LUTHER CAPITAL MANAGEMENT CORP (Filed by) scPharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025 7:01 AM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/07/2025 3:30 PM | scPharmaceuticals (Issuer) Tucker John H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/31/2024 5:04 AM | scPharmaceuticals (Filer)
| Form 10-Q/A | |
12/11/2024 5:30 AM | scPharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:48 PM | Lundbeckfond Invest A/S (Filed by) scPharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024 4:16 PM | scPharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |